NorthCoast Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.22M Buy
28,126
+12
+0% +$531 0.04% 231
2021
Q2
$1.2M Sell
28,114
-765
-3% -$32.2K 0.04% 233
2021
Q1
$1.12M Buy
28,879
+578
+2% +$21.9K 0.05% 222
2020
Q4
$1.02M Sell
28,301
-4,412
-13% -$159K 0.05% 204
2020
Q3
$1.25M Buy
32,713
+30
+0.1% +$1.16K 0.06% 168
2020
Q2
$1.15M Sell
32,683
-193
-0.6% -$6.95K 0.07% 161
2020
Q1
$1.07M Buy
32,876
+214
+0.7% +$8.36K 0.07% 148
2019
Q4
$1.48M Buy
+32,662
New +$1.37M 0.09% 128
2019
Q3
Sell
-9,002
Closed -$387K 227
2019
Q2
$387K Buy
+9,002
New +$346K 0.03% 220
2016
Q4
Sell
-1,646,484
Closed -$39.2M 163
2016
Q3
$39.2M Buy
+1,646,484
New +$39.3M 3.19% 5

Other funds holding BSX

NorthCoast Asset Management's BSX Position: Q3 2021 in Review

NorthCoast Asset Management increased its Boston Scientific (BSX) stake by 0.04% in Q3 2021, buying an estimated $531 and bringing the position to 28,126 shares worth $1.22M. The position accounts for 0.04% of the portfolio, ranked #231.

NorthCoast Asset Management first reported a position in BSX in Q3 2016 and has held it in 10 quarters since. The position peaked at $39.2M in Q3 2016. 878 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • NorthCoast Asset Management held 28,126 shares of Boston Scientific worth $1.22M as of Q3 2021.
  • NorthCoast Asset Management bought 12 Boston Scientific shares in Q3 2021, an estimated $531.
  • Boston Scientific made up 0.04% of NorthCoast Asset Management's portfolio in Q3 2021, its #231 holding.
  • NorthCoast Asset Management first reported a position in Boston Scientific in Q3 2016 and has held it in 10 quarters since.
  • NorthCoast Asset Management's Boston Scientific position peaked at $39.2M in Q3 2016.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.